Chemically induced mouse liver tumors are resistant to treatment with atorvastatin
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Chemically induced mouse liver tumors are resistant to treatment with atorvastatin
Authors
Keywords
Chemical carcinogenesis, HCC, N-nitrosodiethylamine, Ha-ras, Hypolipidemic drug, Oatp1
Journal
BMC CANCER
Volume 14, Issue 1, Pages -
Publisher
Springer Nature
Online
2014-10-15
DOI
10.1186/1471-2407-14-766
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ha-ras and β-catenin oncoproteins orchestrate metabolic programs in mouse liver tumors
- (2014) Elif B. Unterberger et al. INTERNATIONAL JOURNAL OF CANCER
- Statins are associated with reduced risk of gastric cancer: a systematic review and meta-analysis
- (2013) P. P. Singh et al. ANNALS OF ONCOLOGY
- Selective poisoning of Ctnnb1-mutated hepatoma cells in mouse liver tumors by a single application of acetaminophen
- (2013) Yasmin Singh et al. ARCHIVES OF TOXICOLOGY
- Statin use and risk of hepatocellular carcinoma
- (2013) Shih-Wei Lai et al. EUROPEAN JOURNAL OF EPIDEMIOLOGY
- Statins and Reduced Risk of Hepatocellular Carcinoma in Patients With Hepatitis C Virus Infection: Further Evidence Is Warranted
- (2013) Stefanos Bonovas et al. JOURNAL OF CLINICAL ONCOLOGY
- Statins May Protect Against Hepatocellular Carcinoma Development in Patients Infected With Hepatitis C Virus, but What Are the Mechanisms?
- (2013) Sophie Clément et al. JOURNAL OF CLINICAL ONCOLOGY
- Common Flaws in Pharmacoepidemiologic Study Design and Analysis
- (2013) Jennifer L. Lund et al. JOURNAL OF CLINICAL ONCOLOGY
- Statins and the Risk of Hepatocellular Carcinoma in Patients With Hepatitis C Virus Infection
- (2013) Yu-Tse Tsan et al. JOURNAL OF CLINICAL ONCOLOGY
- 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
- (2013) Neil J. Stone et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Statin and aspirin for prevention of hepatocellular carcinoma: What are the levels of evidence?
- (2013) Fabrice Carrat Clinics and Research in Hepatology and Gastroenterology
- Paradoxical cytotoxicity of tert-butylhydroquinone in vitro: what kills the untreated cells?
- (2012) Albert Braeuning et al. ARCHIVES OF TOXICOLOGY
- Statins and cancer: Current and future prospects
- (2012) Maja Osmak CANCER LETTERS
- Novel Aspects of Mevalonate Pathway Inhibitors as Antitumor Agents
- (2012) M. Thurnher et al. CLINICAL CANCER RESEARCH
- Statins and primary liver cancer
- (2012) Danitza Pradelli et al. EUROPEAN JOURNAL OF CANCER PREVENTION
- Common cancer risk and statins: a population-based case–control study in a Chinese population
- (2012) Henry WC Leung et al. Expert Opinion On Drug Safety
- Statins Are Associated With a Reduced Risk of Hepatocellular Cancer: A Systematic Review and Meta-analysis
- (2012) Siddharth Singh et al. GASTROENTEROLOGY
- The pleiotropic effects and therapeutic potential of the hydroxy-methyl-glutaryl-CoA reductase inhibitors in malignancies: A comprehensive review
- (2012) Orlando Santana et al. Journal of Cancer Research and Therapeutics
- Statins and the Risk of Hepatocellular Carcinoma in Patients With Hepatitis B Virus Infection
- (2012) Yu-Tse Tsan et al. JOURNAL OF CLINICAL ONCOLOGY
- Statins and Risk Reduction in Hepatocellular Carcinoma: Fact or Fiction?
- (2012) Preet Paul Singh et al. JOURNAL OF CLINICAL ONCOLOGY
- Potential for statins in the chemoprevention and management of hepatocellular carcinoma
- (2012) Amedeo Lonardo et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- High-dose supplementation with natural α-tocopherol does neither alter the pharmacodynamics of atorvastatin nor its phase I metabolism in guinea pigs
- (2012) Maren C. Podszun et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Pitavastatin suppresses diethylnitrosamine-induced liver preneoplasms in male C57BL/KsJ-db/dbobese mice
- (2011) Masahito Shimizu et al. BMC CANCER
- The analysis of organic anion transporting polypeptide (OATP) mRNA and protein patterns in primary and metastatic liver cancer
- (2011) Katrin Wlcek et al. CANCER BIOLOGY & THERAPY
- MYC Phosphorylation, Activation, and Tumorigenic Potential in Hepatocellular Carcinoma Are Regulated by HMG-CoA Reductase
- (2011) Z. Cao et al. CANCER RESEARCH
- Rosuvastatin Counteracts Vessel Arterialisation and Sinusoid Capillarisation, Reduces Tumour Growth, and Prolongs Survival in Murine Hepatocellular Carcinoma
- (2011) Annemilaï Tijeras-Raballand et al. Gastroenterology Research and Practice
- Inhibition of Autophagy Enhances Anticancer Effects of Atorvastatin in Digestive Malignancies
- (2010) P.-M. Yang et al. CANCER RESEARCH
- Simvastatin inhibits cell growth and induces apoptosis and G0/G1 cell cycle arrest in hepatic cancer cells
- (2010) Relja INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Hepatocellular Carcinoma: Hepatocyte-selective Enhancement at Gadoxetic Acid–enhanced MR Imaging—Correlation with Expression of Sinusoidal and Canalicular Transporters and Bile Accumulation
- (2010) Takahiro Tsuboyama et al. RADIOLOGY
- Statins Are Associated With a Reduced Risk of Hepatocellular Carcinoma in a Large Cohort of Patients With Diabetes
- (2009) Hashem B. El–Serag et al. GASTROENTEROLOGY
- Renal and liver tumors in Tsc2+/- mice, a model of tuberous sclerosis complex, do not respond to treatment with atorvastatin, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor
- (2009) G. A. Finlay et al. MOLECULAR CANCER THERAPEUTICS
- Prediction of the Pharmacokinetics of Atorvastatin, Cerivastatin, and Indomethacin Using Kinetic Models Applied to Isolated Rat Hepatocytes
- (2008) S. W. Paine et al. DRUG METABOLISM AND DISPOSITION
- Statins and cancer: A systematic review and meta-analysis
- (2008) Jaana Kuoppala et al. EUROPEAN JOURNAL OF CANCER
- Contribution of cytochrome P450 3A4 and 3A5 to the metabolism of atorvastatin
- (2008) J.-E. Park et al. XENOBIOTICA
- Differential selection for B-raf and Ha-ras mutated liver tumors in mice with high and low susceptibility to hepatocarcinogenesis
- (2007) Albrecht Buchmann et al. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now